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Abstract
Nanoparticles have been used as diagnostic and therapeutic agents in the human medical field for quite some
time, though their application in veterinary medicine and animal production is still relatively new. Recently,
production demands on the livestock industry have been centered around the use of antibiotics as growth
promoters due to growing concern over microbial antibiotic resistance. With many countries reporting increased
incidences of antibiotic-resistant bacteria, laws and regulations are being updated to end in-feed antibiotic use in
the animal production industry. This sets the need for suitable alternatives to be established for inclusion in feed.
Many reports have shown evidence that nanoparticles may be good candidates for animal growth promotion and
antimicrobials. The current status and advancements of nanotechnological applications in animal production will be
the focus of this review and the emerging roles of nanoparticles for nutrient delivery, biocidal agents, and tools in
veterinary medicine and reproduction will be discussed. Additionally, influences on meat, egg, and milk quality will
be reviewed.
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Background
Nanotechnology is the study of materials at the nano-
scale. With at least one dimension generally ranging
between 1 and 100 nm (10−9 – 10−7m), nanomaterials
are best referred to as particles [1, 2]. These nano-
particles are particularly appealing as they take up very
little space yet have relatively large surface areas, and
therefore an increased ratio between surface atoms and
interior atoms. As a result, when bulky materials are
scaled down to nanosizes, their surface chemistries be-
come more influential and alter the physical properties
of the material [2]. For example, copper is known for its
malleability, a useful feature for wiring and piping.
However, when copper is scaled down into a nanoform,
it loses its malleability as its surface atoms resist bending
[3]. The interior copper atoms in a bulkier form facilitate
bending but are out-numbered by surface atoms in the
nanoform. Enlarging the ratio of surface area to volume
allows for nanoparticles to be more versatile, whether as
a single functional unit, or as a carrier for functional
units which can be adhered to their surfaces or encapsu-
lated within (Fig. 1). Nanoparticles are becoming more
attractive as novel uses, from medical diagnostics to
gene therapy vehicles, are discovered.
Types of nanoparticles
Nanoparticles, currently available or under development,
can be categorized into four groups: metals, polymers,
natural compounds, and nanostructured materials.
Although different engineering techniques are required
depending on the group, nanoparticles can facilitate an
array of biotechnical functions through different mecha-
nisms of action (Table 1). Metal nanoparticles are the
powdery version of solid metal, after large pieces have
been ground down to nanosizes, effectively changing its
associated physical properties [4]. These particles have
drawn the attention of the medical field for their use in
imaging and as antimicrobial therapies that lyse Gram
positive and Gram negative bacterial cell walls [5].
External or topical applications may be more suitable for
some metal nanoparticles to avoid accumulation in the
body, as certain species can elicit harmful dosage-
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toxicity responses, although this is not always the case
[6–8]. The non-biodegradable nature of metal is a major
drawback for these particles. Polymeric nanoparticles, or
nano-polymers, are polymers that have been synthesized
or fragmented into pieces that are nanometers long.
Nano-polymers have the ability to be grafted onto other
materials, potentially improving their biocompatibility
and degradation while expanding their utility [8].
Biocompatibility is highly advantageous for the medical
and food industries as working concentrations of bio-
compatible nanoparticles will have few to no negative side
effects on patients or consumers [9–12]. Similar to the
metal varieties, polymeric nanoparticles with a fluorescent
or radiolabeled component may be used for medical
Nanoparticle Action
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Fig. 1 Three basic systems of nanoparticles in their applications. Nanoparticles can serve as the functional unit (a) but can also act as a delivery
vehicle for materials conjugated to their surface (b) or encapsulated within (c)
Table 1 Mechanisms of action for nanoparticles performing a function useful to animal production
Function Type of Nanoparticle Mechanism of Action References
Nutriceuticals Metal - feed supplements at the nanoscale are more bioavailable to
animals than at a microscale, allowing more interactions to
occur in the gut and better absorbance
[27, 38, 47, 51, 52]
Natural - nanoparticle additives to food products for human
consumption can increase bioavailability
[55]
Drug and Nutrient Delivery Polymer - can be loaded with traditional antibiotics and may act as a
shuttle to release them when in close proximity to a pathogen
[41–43]
- metal nanoparticles may be conjugated to polymers for a
combined nutrient/biocide delivery approach
[48, 49]
Natural - enclose around nutrients to protect against their degradation
in the stomach for maximum intestinal absorption
[21]
Nanostructured -designed to carry nutrients or pharmaceuticals through the
gastrointestinal tract for targeted release
[26, 66, 67]
Biocides Metal - lyse negatively charged Gram + and Gram – bacterial cell walls [5, 31, 32, 53]
Polymer - destabilize bacterial cell walls such that homeostasis is
disrupted to a lethal extent
[33, 44, 45]
Diagnostic Tools Metal - magnetic metal nanoparticles can disperse throughout the
body and be imaged via MRI
[60]
Nanostructured - fluorescence can be initiated via light activation or
two-photon excitation
[61, 62, 65]
Reproductive Aids Nanostructured - purification of sperm through the removal of damaged
spermatozoa via surface markers recognized by
nanoparticle-bound antibodies or lectins
[75, 76]
Molecular Biology Agents Nanostructured - gene transfer mediation through interactions between nucleic
acids, nanoparticles, and sperm
[81]
Polymer - DNA transfection vehicles (as above) [82]
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imaging, although dosage toxicity would still have to be
considered [13]. Nanoparticles made of natural com-
pounds are materials that come from nature with limited
manipulation, such as natural polymers or proteins. With
few alterations, natural compounds are more likely to be
biocompatible, distributable in the body, and biodegrad-
able. Nanostructured materials are synthesized nano-
particles that originate from many sources, including
natural compounds such as lipid- and protein-based
nanoparticles. Natural and nanostructured nanoparticles
share many advantages and can serve as the sole function-
ing unit or carriers for functional groups, such as drugs
and nutrients, via encapsulation or superficial adhesion.
While nature-derived nanomaterials may seem a safer
choice, these particles could elicit toxic or immunogenic
responses if not carefully engineered or appropriately dis-
tributed in a biological system. Despite these potential
limitations, the advantages of employing nanotechnology
are far greater.
Applications of nanotechnology
Current applications of nanotechnology in the medical
and food industries are relatively analogous. Medical
diagnostics and food safety testing are being improved
through lab-on-a-chip technologies, capitalizing on the
large surface area and small volume of nanoparticles.
These molecular technologies require less samples,
shorter run times, and provide a simpler user experience
without the need for large bench top machines [14, 15].
A major advantage of lab-on-a-chip technologies is the
ability to generate real-time data in the field. Thera-
peutic nanoparticles and nanoparticles as therapy deliv-
ery systems are both growing interests in the medical
field and parallel the food industry where nanoparticles
are being investigated as nutraceutical delivery systems,
and biocides to better preserve food stuffs. Germicidal
metal and polymeric nanoparticles attack the integrity of
microbial cell walls, while natural and nanostructured
materials can entrap and protect nutrients for delivery.
The complementary nature of the medical and food in-
dustries is best exemplified in animal production where
livestock health is directly linked to food safety. Live-
stock producers require their herds and flocks to reach
ideal slaughter weights rapidly to maximize profitability.
To achieve this, antibiotics are currently used prophylac-
tically as feed additives to prevent illness and accelerate
growth, thus shortening animal production cycles [16].
While helpful from the production standpoint, this glo-
bal practice has led to the rise of drug-resistant bacteria
that can cause illness in livestock and contaminate meat
[17]. Trends in antibiotic use from various countries
show that the majority is used in agriculture and less in
humans [18]. This has prompted several countries to
pass legislation restricting the use of antibiotics in
animal production [19]. Nanoparticles not only have the
potential to fill the gap created by these restrictions, but
can also do so without driving antibiotic-resistance in
microbes. Further to this, nutrient delivery, biocides, vet-
erinary medicine, and reproduction are areas of the ani-
mal production industry that could benefit from
nanotechnology, and the advantages and limitations of
their inclusion will be discussed in this review (Table 2).
Nutrient delivery
Casein micelles are naturally occurring nanoparticles in
milk, where casein phosphoproteins make up approxi-
mately 80% of the protein profile in cow’s milk [20, 21].
Some casein isoforms assemble themselves around cal-
cium, proteins, and other nutrients to allow for transport
from mother to young. Manipulation of these micelles
has led to the incorporation of choice hydrophobic nu-
trients [22]. Vitamin D was dispensed to human volun-
teers within these casein nanoparticles, increasing
vitamin D bioavailability in vivo, as casein particles
undergo proteolytic cleavage in the stomach, releasing
their encapsulated vitamins [21]. A similar strategy could
be investigated to help producers assist neonates
through weaning, a sensitive time for young as their
digestive and immune systems are still maturing. In the
absence of milk from the mother, weanlings must adapt
to a complex carbohydrate diet and reduced immune
support. This is an important stage not only for animal
welfare reasons, but also from a production standpoint
as weanlings that maintain their growth rates through
the weaning process are healthier and heavier by
slaughter [23]. Benefits from nutritional supplements
may help weaned animals and poultry increase body
size as well [24]. Nanoparticles engineered for nutri-
ent delivery could facilitate this supplementation and
bolster growth rates of livestock by increasing nutri-
ent cargo bioavailability.
Orally administering additional nutrients to livestock
via feed brings inherent challenges that must be consid-
ered when designing a carrier nanoparticle. Each
compartment of the gastrointestinal tract has a unique
environment that includes its own complement of en-
zymes and specific pH level. Nanoparticles must be able
to overcome these obstacles to deliver their nutritional
cargo at the appropriate location, i.e. the small intestine
[25]. Akbari and Wu [26] investigated a nanoparticle
made from the canola protein cruciferin, and demon-
strated that these nanoparticles could encapsulate both
hydrophobic and hydrophilic bioactive compounds, pro-
tect them from a simulated stomach environment, and
release them in a simulated intestinal environment.
Once nutrients are released from nanoparticles, they
must reach the intestinal epithelia and carry out their
function as if they were to have originated from the feed.
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The nanoparticle cannot remain in the intestine, as accu-
mulation may prevent the absorption of other nutrients in
the lumen. Cellular uptake, degradation, or removal from
the body must occur. Depending on the type of nano-
particle, cellular uptake may not be preferred in the animal
production industry where food safety must be considered.
Cruciferin nanoparticles are digestible in the small intestine
by the pancreatin enzyme, however, indigestible nano-
particle vehicles may be excreted naturally. Before entering
the market, a thorough study of nanoparticle action must
be done to test for potency and any unwanted biological
consequences, like cytotoxicity.
Table 2 Current and future applications of nanotechnology in animal production with their advantages and limitations
Advantages Limitations References
Current applications
Medical diagnostics - disease diagnosis and prognosis
- small sample volume requirements
- faster sample analyses; faster action time
- suitable for field use
- greater sample preparation measures




Medical supplies - antibacterial wound dressings
- prevention of catheter-caused infections
- inhibits biofilm formation
- patient sensitivities and allergies
- potential free radical formation
[85, 86]
Food safety - contaminant and pathogen identification
and indication
- contamination prevention
- food and food packaging safety concerns [53, 55]
Biocides - alternatives to antibiotics and
conventional cleaners
- internal and external uses
- antimicrobial coatings
- multi-purpose (i.e. bactericidal
and growth promoting)
- little in vivo evidence to support
many internal applications demonstrated
in vitro
- cytotoxicity
[31–34, 44, 45, 85, 86]
Future applications
Nutraceuticals - increased nutrient bioavailability
- extra support for weanlings
- growth and performance enhancement
- solution for nutrient deficiencies
- nanoparticles must be not be degraded
in the GI tract before absorption in the intestines
[27, 38, 47–52, 59]
Nutrient delivery systems - increased nutrient bioavailability
- extra support for weanlings
- growth and performance enhancement





Therapeutics - alternatives to antibiotics
- enhanced pathogen/organ targeting
- biocompatibility considerations
- efficacy against different pathogens
- relative MIC
[41–43, 53]
Drug delivery systems - platforms to enhance drug specificity
and delivery
- reduce MIC and kill antibiotic-resistant
strains of pathogens
- biocompatibility considerations
- potential for bodily accumulation
- confidence in specificity
[61, 62, 65–67]
Medical Imaging - additional modes of tracing organ
systems and tracking drug therapies
in the body
- depth of tissue
- biocompatibility considerations
[61, 62, 65]
Nanopurification of sperm - isolate desired sperm based on biomarkers
(i.e. healthy from unhealthy)
- increase fertilization efficiency,
more females fertilized from a
single collection
- biomarker library to be developed
- purebred restrictions on artificial insemination
[75, 76, 83, 84]
Cryopreservation of sperm - sperm preserved for longer
- protecting against freeze-thaw cycles
- to replace antibiotics from extenders;




Genetic manipulation - can carry DNA of interest from cytoplasm
into cell nucleus
- benefits to sperm-mediated gene
transfer approach
- transduction replacement strategy
(no viruses involved in DNA administration)
- cytotoxicity
- must not disturb cellular functioning
[81–84]
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While nutrient delivery at the nanoscale can occur
naturally or synthetically, nanoparticles can stabilize
bioactive compounds and assist in cellular uptake. To
add a bioactive component directly to feed entails a
risk of degradation and inaccessibility that can be
countered through nanotechnological means. The
small size of nanoparticles garners a heightened level
of bioavailability compared to microparticles, particu-
larly in the digestive tract, since nanoparticles can
more readily pass through the intestinal mucosa.
Huang et al. [27] used calcium carbonate and calcium
citrate at the nano- and microscales to test bioavail-
ability differences by measuring bone mineral dens-
ities of mice. Mice that were administered the
calcium compounds at the nanoscale had denser
bones compared to mice given micro-calcium and
controls. It would be of interest to investigate
whether delivering calcium in nanoform may help to
strengthen bones of production animals such as tur-
keys, as body mass is heavily selected for over leg
strength, making it difficult for turkeys to support
themselves [28].
Biocides
Nanoparticles may present a feasible alternative to anti-
biotics and may help bar pathogens from entering ani-
mal production sites. The unregulated use of antibiotics,
a common practice in many countries, provides the im-
petus for bacteria to become drug-resistant. New legisla-
tion for the restriction of prophylactic antibiotic use in
agriculture is gaining ground as a method to combat this
growing problem [29]. Limiting antibiotic use necessi-
tates the development of alternatives due to the high-
density nature of modern animal production facilities
which invites and expedites disease transmission [30].
Metal nanoparticles with net positive charges are drawn
to negatively charged bacterial membranes, resulting in
leakage and bacterial lysis [31]. Kim et al. [32] found that
silver nanoparticles could inhibit the growth of
hemorrhagic enteritis-inciting E. coli O157:H7 and yeast
isolated from a case of bovine mastitis with an estimated
MIC of 3.3-6.6 nmol/L and 6.6-13.2 nmol/L, respect-
ively. At present, silver is used in medicine and dentistry
to prevent wound infections and the formation of
biofilms on catheters and dental appliances. Similarly,
positively charged and/or quaternized polymeric nano-
particles can limit microbe growth [33]. Qi et al. [34]
tested the antimicrobial activity of chitosan, a biopoly-
mer with a positive surface charge (Zeta potential of
approximately +51 mV), against a variety of bacterial
pathogens and concluded that the MIC for all species
tested was smaller than 0.25 μg/mL. Current biosecurity
measures can impede pathogen entry but feed, water, air,
and personnel may still serve as accession points [35].
The use of antimicrobial nanoparticles at these points
may create additional hurdles for potential pathogens
seeking entry.
Copper is regularly added to feeds for its ability to
promote animal growth and performance in addition to
its antimicrobial properties [36, 37]. As copper is deliv-
ered to animals orally in feed, the same challenges seen
in nutrient delivery can be applied here. It has been re-
ported that copper nanoparticles pass intestinal mucosa
more easily than microforms, aiding in absorption.
Gonzales-Eguia et al. [38] demonstrated that nanoform
copper could better improve piglet energy and crude fat
digestion through the augmentation of lipase and
phospholipase A activity in the small intestine compared
to a basal diet supplemented with CuSO4. These piglets
experienced an increase in daily weight gain, metabolic
rates, and immune capacity. Analysis of nanocopper in-
fluence on the immune system showed significantly
greater total globulin and superoxide dismutase concen-
trations in blood serum, although hematology was un-
changed among experimental groups. These results
suggest that the nutrient value of feed can be enhanced
through the addition of antimicrobial metal supplements
in nanoform. However, further investigation is required
before determining whether antibiotics in feed can be
completely replaced by nano-antimicrobials.
Despite the expansion of antibiotic-resistance in bac-
teria, antibiotics have not yet been rendered totally inef-
fective against them. Their delivery and efficacy can be
enhanced by nanoparticle carriers, potentially decreasing
the dosage of antibiotics required for treatment. Suscep-
tible bacteria lack at least one mechanism of resistance
where resistant bacteria have, at minimum, one of the
many known resistance mechanisms [39]. β-lactamases
are resistance enzymes that cleave the β-lactam ring in
β-lactam drugs such as penicillin and methicillin,
destroying drug activity [40]. Loading penicillin onto
polymeric polyacrylate nanoparticles has been identified
as an effective method of making the β-lactam ring
insusceptible to β-lactamase binding and cleavage,
restoring penicillin function against methicillin-resistant
Staphylococcus aureus (MRSA), a penicillin- and
methicillin-resistant bacterial strain [41]. In a study by
Turos et al., different penicillin-polyacrylate nanoparticle
preparations were examined and it was found that two
of them could inhibit MRSA just as well as the positive
control, Penicillin G, and that one of the two had an
MIC 8× lower than that of Penicillin G (2 μg/mL versus
16 μg/mL) [41]. No evidence of toxicity was seen during
either the systemic or topical application of these nano-
particles in a murine model, and when applied topically
to a dermal abrasion, the healing time was shortened by
3–5 d [42]. A similar study was performed using
tetracycline-bound polymeric chitosan nanoparticles
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against a tetracycline-resistant Escherichia coli strain, re-
quiring a minimum concentration of 700 μg/mL for in-
hibition of bacterial growth [43].
Nanoparticles made from natural materials that target
Gram negative bacteria are most desired for feed, since
bacterial pathogens are predominately Gram negative.
This is due to the Gram-negative endotoxin, lipopolysac-
charide (LPS), that is absent in Gram positive bacteria. It
is important to monitor the materials provided to food
animals as the bodily accumulation of toxins could pose
a threat to consumers and potentially dampen public
opinion towards the inclusion of nanotechnology in ani-
mal production, highlighting the importance of only
selecting biocompatible nanoparticles for use in feed.
However, the addition of nanoparticles in feed is not the
only solution to limit livestock exposure to pathogens;
the external application of hydrogels could assist in pre-
venting pathogens from entering production facilities.
Quaternization, which gives amine groups a permanent
positive charge, of polymer nanoparticles such as poly(2-
(dimethylamino)ethyl methacrylate) (qPDMAEMA)
permits biocidal activity through electrostatic attraction
between polymer and microbe, distorting the cell wall
[33]. When qPDMAEMA is grafted onto agarose or cel-
lulose nanocrystals, they can be made into hydrogels and
used to cover surfaces to prevent bacterial adhesion,
colonization, and biofilm formation. Their ability to bind
viruses and virus-like particles has also been reported
[44]. Moreau et al. [45] examined the biocompatibility of
a few cationic polymers in vitro and in vivo and con-
cluded that toxicity was dependent upon the molar mass
of the polymer and the type of polycation. The unqua-
ternized PDMAEMA (193.5 Da) was found to induce
hemolysis and cause immediate mortality when adminis-
tered intravenously in mice, indicating that its use as a
biocide should be restricted to external purposes only,
and should not be included in feed. Spreading biocidal
hydrogels and nano-solutions across thresholds, pens,
and feed containers presents yet another use that would
benefit from further study [46].
Meat and egg quality
The possibility of using nanoparticles to enhance meat
and egg quality has also been investigated. For example,
Wang and Xu [47] demonstrated that when finishing
pigs destined for market were given chromium nanopar-
ticles (200 μg/kg) in feed, they were 14.06% leaner at
slaughter than control pigs fed a basic diet of corn-
soybean meal. An increase in skeletal muscle mass and
improved pork quality were achieved, with similar effects
found when finishing pigs were fed chitosan nanoparti-
cle supplements loaded with chromium [48, 49]. These
chromium-loaded chitosan nanoparticles elevated the
activity of hormone-sensitive lipase in adipose tissue
while decreasing fatty acid synthase activity and boosting
blood serum immune components [48, 49]. These data
provide a compelling insight into the mechanism of ac-
tion these nanoparticles have in pigs, and how they
affect meat quality. Of further interest is the heightened
chromium content in selected tissues, such as 184.11%
in the longissimus muscle compared to the control, as
some nanoparticles, i.e. Ag+ and Cu2+, have been found
to cross the blood–brain barrier [47, 50].
The inclusion of nanomaterials in livestock feed or
water can benefit the quality of product obtained, as well
as the production cycle. Chromium nanoparticles added
to poultry feed not only positively affected breast and
thigh muscle protein content while simultaneously low-
ering cholesterol, but raised the average daily gain and
feed efficiency of the broilers in the experimental group
fed 500 μg/kg Cr3+ [51]. The implications of these re-
sults are shorter production cycles for better quality
meat with less feed required to have broilers reach mar-
ket weight. Conversely, when chromium nanoparticles
were supplied to layers, there was no significant effect
on body weight or egg production [52]. However, Sirirat
et al. [52] did find that egg quality improved from higher
chromium and calcium levels in the yolks and shell, re-
spectively. Bioaccumulation of nanoparticles in the liver
was noted for the experimental group, an observation
shared with Chauke and Siebrits [53] in a study that re-
placed an antibiotic against coccidiosis with silver nano-
particles in water (0.083 mg/kg of silver compared to
0.001 mg/kg in the control). More information on the
interplay between nanoparticle concentration and meat
quality would be useful to ensure that quality is not
sacrificed after long-term exposure [54]. The inclusion
of nutrient supplements in livestock feed, regardless
of particle size, will benefit the producer if there is
still consumer demand for the final product. If meat
and eggs obtained from an animal fed nanoparticle
supplements are enhanced, or indiscernible from the
original product, they are then likely to still be
favourable to consumers. However, it is important to
understand the role of the nanoparticle additive in a
given biological system and by-products from that
system to ensure it is safe for consumption before its
application in animal production.
Milk
Mastitis is an example of a common ailment among
dairy cows with a variety of inciting factors, often bacter-
ial, that can require the use of antibiotics to clear. Tilmi-
cosin is an example of a drug used in mastitis cases that
has negative side-effects if given at too high a concentra-
tion. In consideration of this, Han et al. [55] sought to
control the release of tilmicosin by using hydrogenated
castor oil-solid lipid nanoparticle carriers. Of concern
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was what the extended half-life of the therapeutic would
mean for milk discard times, as tilmicosin was present
in mouse blood serum for 5 h without nanocarrier
delivery, and 8 d with nanocarrier delivery [55].
However, a lower dosage was required for resolution in a
S. aureus-induced murine mastitis model (10 mg/kg
versus 20 mg/kg) [56]. Careful manipulation of thera-
peutic nanocarriers to find a balance between dosage
and half-life could serve to benefit producers by minim-
izing milk discard times and the amount of milk wasted.
Nanotechnology can also help to ensure that the
quality of milk is safe for human consumption through
novel foodborne pathogen detection techniques. Sung et
al. [57] developed nanocomposites containing anti-S.
aureus antibodies, gold nanoparticles, and magnetic
nanoparticles to provide a 40 min colorimetric test for
the presence of S. aureus in milk. An interesting feature
of these nanocomposites is the antibody, whose specifi-
city and selectivity could be modified to capture a variety
of pathogens [57]. Wang et al. [58] demonstrated a simi-
lar technique, employing polyclonal antibodies and gold
nanoparticle immunochromatographic strips to detect
toxins present in milk within 10 min, using the carcino-
genic aflatoxin M1 as an example. While a large focus
has been to remove potentially harmful contaminants
from milk, there has also been some interest in mixing
nanoparticle supplements directly into cow’s milk for
human consumption. Lee et al. [59] combined nano-
powdered oyster shell into milk with the intention of
increasing the calcium content from 100 to 120 mg/mL
to a level more suitable for growing children and post-
menopausal women. Supplementing milk with calcium
from nanopowdered oyster shell did not negatively alter
its sensory or physicochemical qualities after 16 d of
storage at 4 °C [59].
Veterinary medicine
Nanomedicine is an intriguing discipline in nanotechnol-
ogy that is showing progress in both diagnostics and
therapeutics. Metallic and nanostructured particles are
useful diagnostic tools in biomedical research that can
be used to visualize the status of a cell or drug distribu-
tion in the body. Magnetic nanoform metals, i.e. iron
oxide, can be taken up by cells and imaged in vivo at
high concentrations using magnetic resonance imaging
(MRI) [60]. Nanostructured particles can be made to
fluoresce through light activation or two-photon excita-
tion [61, 62]. Further to these diagnostic nanoparticles,
exciting developments have been made in molecular-
based lab-on-a-chip technologies for qualitative and
quantitative biological analyses. Requiring small volumes
of analyte and reagents, producing little waste, and
shortening wait times make these lab-on-a-chip tech-
nologies an attractive option [63]. There are currently a
number of products functioning at the microscale avail-
able on the market with nanoscale products just emer-
ging; see Tian et al. [64] for more information.
Drug delivery can be monitored through fluorescent
nano-carriers. For example, light activated, fluorescent
nanostructured glucose- and sucrose-derived nano-
particles can be used to monitor the localization of
bound chemotherapies [61]. The biocompatibility of
carbohydrate-derived nanoparticles has been demon-
strated in a human lung carcinoma cell line by Ajmal
et al. [61]. Their findings showed that upon binding
methotrexate, a chemotherapeutic drug, the conjugate
nanoparticles were reported to have a cytotoxicity
close to that of cells treated only with methotrexate.
However, the advantage of delivering this drug with a
nanoparticle that fluoresces after light activation is
the ability to trace the drug. For even better tracking,
using a carrier nanoparticle capable of being activated
via two-photon excitation can provide a 3D spatial
image over a greater tissue depth than a particle acti-
vated with visible UV light [62, 65]. As chemother-
apies are typically delivered in a high dose regimen,
the ability to observe their distribution in the body
through fluorescence could help to reduce off-target
side effects by better targeting them to desired areas.
Fluorescence is not a shared trait among all nanoparti-
cle drug carriers, and their mechanisms of drug binding
and release can be quite varied, especially amongst
nanostructured particles. Cylindrical nanotubes can trap
pharmaceutical agents within an internal matrix sur-
rounded by an outer layer of poly (L-lactide) or poly (D-
lactide) [66]. When these enantiomers come together in
solution, they interact with each other to reconfigure
their structures from cylinders to spheres, releasing
trapped materials in the process. There is no require-
ment for external stimuli for drug release as there is in
some light activated nanoparticles, only that the two
nanotubes interact. Other nanostructured particles can
be self-loading like albumin-dextran nanoparticles with
hydrophobic drugs [67]. Albumin from bovine serum
can be stabilized with dextran in aqueous solutions and
can bind medicine through hydrophobic and electrostatic
interactions. When tested with ibuprofen, albumin-
dextran nanoparticles could take up 0.7-unit weight of
ibuprofen per 1-unit weight of the conjugated particle
[67]. These nanostructured materials present new
mechanisms for pharmaceutical uptake and release in
nanomedicine, potentially serving as methods to increase
release specificity and reduce lag times between drug
delivery and effect in the future.
Reproduction
Animal production revolves around animals meant for
slaughter. Finishing livestock are the offspring of
Hill and Li Journal of Animal Science and Biotechnology  (2017) 8:26 Page 7 of 13
individuals intended for breeding who have highly
ranked genotypes and phenotypes. The traits and repro-
ductive abilities of breeders gives them high value. Some
nanoparticles have been demonstrated to enhance fertil-
ity and protect spermatozoa through the functional
groups they carry. Artificial insemination is widely pre-
ferred in animal production as an alternative to live
cover strategies due to the lower risk for animals and
producers. Commonly done to diversify genetic back-
grounds and boost selection of livestock traits, artificial
insemination has the potential to be enhanced through
the integration of nano-techniques such as the non-
invasive bioimaging of gametes, nanopurification, and
protectants in cryopreservation.
In order to optimize the efficiency of artificial insemin-
ation, livestock gamete biology and reproductive obsta-
cles to fertilization must first be elucidated. Recently,
quantum dots have been explored as a research method
to improve understanding of mammalian spermatozoon
and oocyte movement and their interactions in a physio-
logical setting. These self-illuminating, inorganic nano-
particles are of interest to the field of theriogenology as
they are biocompatible, photo-stable, and have a greater
signal intensity than organic fluorescent molecules previ-
ously used to image gametes and other cell types in vivo
[68–70]. Feugang et al. [68, 71] have demonstrated the
real-time tracking ability of bioluminescent resonance
energy transfer-conjugated quantum dot (BRET-QD)
nanoparticles in vitro, in situ, and ex vivo using pig male
gametes (Sus scrofa domesticus). Quantum dots can pro-
vide targeted or non-targeted imaging as a function of
their size, emitted wavelengths, and conjugation possibil-
ities [68, 71]. This engineered nano particle provides a
new mean to visualize the molecular and cellular
events during fertilization, in a similar way to fluores-
cent proteins, but at greater tissue depths [71, 72].
Signal strength of quantum dots are dose-dependent
and a higher concentration may be required for in
vivo imaging on larger animals. Thus, the compos-
ition of quantum dots should be further optimized
for biocompatibility as many of the current ones
include heavy metals, such as cadmium and lead,
which may be cytotoxic at high levels [73]. However,
if quantum dot concentrations and surface chemistries
are carefully selected, cytotoxicity may be decreased
or eliminated [74].
Nanopurification of semen can be used to separate
damaged sperm from undamaged, healthy sperm. One
method is to coat magnetic nanoparticles with anti-
bodies against ubiquitin, a surface marker of defective
sperm, for a protein-based removal strategy [75]. A
lectin-based strategy features magnetic nanoparticles
coated with lectins that bind glycan exposed at the
surface of the sperm through acrosomal damage [76].
Nanopurified bull spermatozoa (Bos taurus) achieved
conception rates equal to those of unpurified semen at
half the concentration with no negative impacts reported
for inseminated cows or calves [75]. Thus, more females
can be inseminated from one sample of nanopurified, di-
luted ejaculate. Further identification of spermatozoa
biomarkers will allow for increased selection ability and
fertility improvement, as targeted through the antibody
or lectin strategies.
Cryopreservation of sperm can be enhanced by turn-
ing to nano-protectant additives in extenders. Used to
dilute sperm, extenders are buffering agents and provide
sperm with nutrients required for prolonged storage.
They serve to protect and contain antibiotics, to prevent
bacterial growth from affecting sperm quality and infect-
ing inseminated females [77]. Antimicrobial nanoparti-
cles may serve to replace extender antibiotics in the
future as some antibiotics have been shown to inhibit
sperm motility and viability in a dose-dependent manner
[78]. Nanoparticles may also facilitate the addition of
natural products in extenders to increase sperm motility.
Research groups have reported that the addition of
honey, sugarcane juice, tomato juice, and pineapple juice
can increase the survivability of sperm stored at room
temperature [76, 79]. While nanoparticles were not in-
volved in those studies, it would be interesting to know
how sperm quality would be effected if the functional
groups of each product were to be delivered via nano-
particle. As sperm can be shipped internationally over
multiple days, extenders with a higher capacity for pre-
serving samples undergoing freeze-thaw cycles would be
beneficial [80].
Further advancements in reproductive biotechnology
may be possible with the greater inclusion of nanoparti-
cles in molecular biology techniques. Sperm-mediated
gene transfer is onesuch approach where mesoporous
silica nanoparticles can be loaded with nucleic acids and
proteins [81]. These nanoparticles can form strong
associations with spermatozoa in vitro, and do not have
any diminutive effects on sperm function or quality.
Transfections with polymeric nanoparticles, such as
PDMAEMA, chitosan, and polyethylenimine, have been
reported to be advantageous over traditional viral
approaches provided low concentrations of polymers are
used [82]. The molecular weight of the nanopolymer has
great influence over transfection efficacy and toxicity, i.e.
the optimal molecular weight for transfection with
PDMAEMA has been determined to be 60 kDa [82].
With continued exploration and refinement, nano-
particles could play a significant role in animal
reproduction. However, it should be noted that some
nanoparticles are spermatotoxic which may have serious
consequences if breeder reproduction is affected. Zinc
oxide and titanium oxide nanoparticles are two examples
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that reduce in vitro sperm viability in a dose- and time-
dependent manner by membrane weakening and DNA
fragmentation [83, 84]. Barkhordari et al. [83] incubated
human sperm with zinc oxide nanoparticles and found
that a concentration of 500 μg/mL would significantly
increase cell death after 45 min, while a concentration of
100 μg/mL would significantly increase cell death after
180 min. Pawar and Kaul [84] found that buffalo sperm
(Bubalus bubalis) incubated with 100 μg/mL of titanium
oxide nanoparticles would have reduced viability. At
10 μg/mL titanium oxide was found to prematurely
increase sperm capacitation, which is the final required
step in sperm maturation for oocyte penetration and
fertilization. While nanoparticles may be points of
advancement for the animal production industry,
precautions should also be taken when considering the
employment of nanoparticles for assisting reproduction.
Future prospects
As nanotechnology continues to develop and garner
more attention, its applications in the animal production
industry will become more expansive. The regular
inclusion of nano-supplements to fortify livestock feed is
likely possible in the near future; however, it will take
longer for nanoparticles to fully replace antibiotics in
feed as many biocidal candidates must still be tested in
vivo before undergoing clinical trials and food safety
tests in accordance with government regulations. Exter-
nal uses for nanoparticles have already been integrated
into some aspects of animal production, i.e. antiseptic
wound dressings, and more are to follow [85, 86]. For
studies interested in nanoparticles with anti-cancer
properties, it is important to investigate nanoparticle
cytotoxicity in both cancer cell lines and normal, healthy
cell lines. Only using cancer cells and claiming the nano-
particle under investigation has anti-cancer properties
may be misleading, as the nanoparticle may be cytotoxic
to all cell types. In vivo studies are needed for verifica-
tion of nanoparticle functions seen in in vitro research.
Table 3 outlines nanoparticle experiments relevant to
the animal production industry and identifies gaps in
knowledge where future research will be required.
Conclusions
There are many applications for nanoparticles in animal
production and this review serves to highlight these uses
and to identify potential opportunities for future applica-
tions. Nanoparticles are already available on the market
and, with continued development, their properties will
be more finely optimized for a wider selection of appli-
cations. The use of nanotechnology in animal produc-
tion is still in its infancy but encouraging results from
nutrition, biocidal, remedial, and reproductive studies
are driving further investigation.
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